What did we learn from the OPTIMAAL trial? What can we expect from VALIANT?

被引:7
作者
Dickstein, K [1 ]
机构
[1] Univ Bergen, Cent Hosp Rogaland, Stavanger, Norway
关键词
ACUTE MYOCARDIAL-INFARCTION; RANDOMIZED-TRIAL; HEART-FAILURE; MORTALITY; MORBIDITY; LOSARTAN; CAPTOPRIL; VALSARTAN; SURVIVAL;
D O I
10.1016/S0002-8703(03)00168-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:754 / 757
页数:4
相关论文
共 21 条
[1]  
ABBAS A, 1999, AM HEART J, V138, P1133
[2]   THE EFFECT OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR ZOFENOPRIL ON MORTALITY AND MORBIDITY AFTER ANTERIOR MYOCARDIAL-INFARCTION [J].
AMBROSIONI, E ;
BORGHI, C ;
MAGNANI, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (02) :80-85
[3]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[4]   DESMOPRESSIN AND BLOOD-LOSS AFTER CARDIAC-SURGERY [J].
CATTANEO, M ;
MANNUCCIO, P ;
MANNUCCI .
LANCET, 1993, 342 (8874) :812-812
[5]   A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure [J].
Cohn, JN ;
Tognoni, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) :1667-1675
[6]  
COLLINS R, 1995, LANCET, V345, P669
[7]   Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].
Dahlöf, B ;
Devereux, RB ;
Kjeldsen, SE ;
Julius, S ;
Beevers, G ;
de Faire, U ;
Fyhrquist, F ;
Ibsen, H ;
Kristiansson, K ;
Lederballe-Pedersen, O ;
Lindholm, LH ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wedel, H .
LANCET, 2002, 359 (9311) :995-1003
[8]  
DEVITA C, 1994, LANCET, V343, P1115
[9]   Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAL randomised trial [J].
Dickstein, K ;
Kjekshus, J .
LANCET, 2002, 360 (9335) :752-760
[10]   Indications for ACE inhibitors in the early treatment of acute myocardial infarction -: Systematic overview of individual data from 100,000 patients in randomized trials [J].
Franzosi, MG ;
Santoro, E ;
Zuanetti, G ;
Baigent, C ;
Collins, R ;
Flather, M ;
Kjekshus, J ;
Latini, R ;
Liu, LS ;
Maggioni, AP ;
Sleight, P ;
Swedberg, K ;
Tognoni, G ;
Yusuf, S ;
Tavazzi, L ;
Ball, S ;
Kober, L ;
Torp-Pedersen, C ;
Braunwald, E ;
Moyé, L ;
Pfeffer, M ;
Santoro, L ;
Pogue, J ;
Wang, Y .
CIRCULATION, 1998, 97 (22) :2202-2212